- Home
- SMPL vs VRNA Comparison
SMPL vs VRNA Comparison
Compare SMPL & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMPL
- VRNA
- Stock Information
- Founded
- SMPL 2017
- VRNA 2005
- Country
- SMPL United States
- VRNA United Kingdom
- Employees
- SMPL N/A
- VRNA N/A
- Industry
- SMPL Packaged Foods
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- SMPL Consumer Staples
- VRNA Health Care
- Exchange
- SMPL Nasdaq
- VRNA Nasdaq
- Market Cap
- SMPL 3.4B
- VRNA 2.9B
- IPO Year
- SMPL 2016
- VRNA 2017
- Fundamental
- Price
- SMPL $38.51
- VRNA $38.52
- Analyst Decision
- SMPL Buy
- VRNA Strong Buy
- Analyst Count
- SMPL 9
- VRNA 6
- Target Price
- SMPL $39.67
- VRNA $43.83
- AVG Volume (30 Days)
- SMPL 948.9K
- VRNA 1.1M
- Earning Date
- SMPL 01-02-2025
- VRNA 11-04-2024
- Dividend Yield
- SMPL N/A
- VRNA N/A
- EPS Growth
- SMPL 4.55
- VRNA N/A
- EPS
- SMPL 1.38
- VRNA N/A
- Revenue
- SMPL $1,331,321,000.00
- VRNA $5,624,000.00
- Revenue This Year
- SMPL $11.84
- VRNA N/A
- Revenue Next Year
- SMPL $6.18
- VRNA $554.09
- P/E Ratio
- SMPL $27.54
- VRNA N/A
- Revenue Growth
- SMPL 7.13
- VRNA 1127.95
- 52 Week Low
- SMPL $30.00
- VRNA $11.39
- 52 Week High
- SMPL $43.00
- VRNA $40.13
- Technical
- Relative Strength Index (RSI)
- SMPL 74.56
- VRNA 63.57
- Support Level
- SMPL $36.65
- VRNA $34.51
- Resistance Level
- SMPL $39.54
- VRNA $40.13
- Average True Range (ATR)
- SMPL 0.94
- VRNA 2.23
- MACD
- SMPL 0.33
- VRNA -0.07
- Stochastic Oscillator
- SMPL 90.86
- VRNA 89.64
About SMPL The Simply Good Foods Company
The Simply Good Foods Co is a consumer packaged food and beverage company. It provides low-carbohydrate, high protein bars, shakes, and other products such as confections, chips, and cookies under the Atkins and Quest brands. The company distributes its products in retail channels, predominantly in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, and other channels.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.